ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Roma, Lazio

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Colorectal Cancer

Prostate Cancer trials near Roma, Lazio, ITA:

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer (SABRE)

the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...

Active, not recruiting
Prostate Cancer
Device: SpaceOAR Vue System
Boston Scientific
Boston Scientific

Rome, Italy and 29 other locations

(PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer agents in participants with metastatic prostate cancer...

Enrolling
Metastatic Prostate Cancer
Drug: Palacaparib (AZD9574)
Drug: Docetaxel

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Roma, Italy and 36 other locations

The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...

Enrolling
Metastatic Prostate Cancer
Drug: AZD9574
Drug: AZD0516

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Roma, Italy and 51 other locations

The goal of this prospective study is to test the efficacy of Echolaser transperineal focal therapy in patients with low- and intermediate risk prostate...

Enrolling
Prostate Cancer
Procedure: Soractelite Echolaser Transperineal focal laser ablation
San Carlo di Nancy Hospital

Roma, RM, Italy

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Roma, Italy and 345 other locations

docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate...

Active, not recruiting
Metastatic Prostate Cancer
Other: Androgen Deprivation Therapy
Drug: abiraterone acetate

Phase 3

Unicancer
Unicancer

Roma, Italy and 76 other locations

(control) in participants with metastatic Castration Resistant Prostate Cancer (mCRPC) with prior exposure to at least 1 Androgen R...

Active, not recruiting
Prostatic Cancer, Castration-Resistant
Drug: AAA617
Drug: JSB462

Phase 2

Novartis
Novartis

Roma, RM, Italy and 43 other locations

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...

Active, not recruiting
Prostate Cancer
Drug: prednisone
Drug: Leuprolide acetate

Phase 2

Astellas
Astellas

Roma, Italy and 233 other locations

compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...

Active, not recruiting
Metastatic Castration-resistant Prostate Cancer
Drug: Docetaxel
Drug: Abiraterone

Phase 3

Celgene
Celgene

Rome, Roma, Italy and 221 other locations

second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...

Active, not recruiting
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Drug: PF-06821497
Drug: Enzalutamide

Phase 3

Pfizer
Pfizer

Rome, Lazio, Italy and 224 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems